Inhibition of FKBP5 Alleviates Inflammation and Intestinal Barrier Dysfunction in Sepsis
Journal of Interferon & Cytokine Research · 2025
DOI: 10.1089/jir.2025.0046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Interferon & Cytokine Research, 2025. Verfasst von Jian Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, First Affiliated Hospital of Xinjiang Medical University, Urumqi, People's Republic of China. Hauptthemen laut MEDLINE: NF-kappa B, Sepsis, Tacrolimus Binding Proteins, Intestinal Barrier Function. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Themen: Sepsis
Abstract (Originalsprache)
Background
The pro-apoptotic and pro-inflammatory effects of FK506 binding protein 5 (FKBP5) in sepsis-induced acute kidney injury have been previously reported. However, its biological functions and underlying mechanisms in regulating sepsis-induced intestinal injury remain elusive. Therefore, this study aimed to explore the effects of FKBP5 on sepsis-induced intestinal injury.
Methods
A mouse model of sepsis was established by cecal ligation and puncture (CLP). A cell model was established by treating Caco-2 cells with lipopolysaccharide (LPS). The impacts of FKBP5 knockdown on apoptosis, barrier integrity, inflammation, and the nuclear factor kappa B (NF-κB) signaling were evaluated in ileal tissue and Caco-2 cells.
Results
FKBP5 expression was elevated in the ileal tissue in response to CLP and LPS treatments. In mice with sepsis, FKBP5 knockdown reduced cell apoptosis and regulated Bax, Bcl-2, and cleaved PARP levels. FKBP5 knockdown also reduced the levels of D-lactic acid, tumor necrosis factor alpha, interleukin (IL)-6, and IL-1β, improved intestinal histopathological damage, and enhanced the expression of zonula occludens-1 and occludin. FKBP5 knockdown also displayed protective effects in LPS-stimulated cells. FKBP5 knockdown inhibited the NF-κB signaling in CLP and LPS groups.
Conclusion
Inhibition of FKBP5 alleviates inflammation and intestinal barrier dysfunction in sepsis, partially by inhibiting the NF-κB signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, First Affiliated Hospital of Xinjiang Medical University, Urumqi, People's Republic of China.
ORCID-Profile: Zhaoxia Yu
Zitieren
APA
Li, J., Apizi, A., Song, T., Kamilijiang, P., Yu, X., Chai, R., & Yu, Z. (2025). Inhibition of FKBP5 Alleviates Inflammation and Intestinal Barrier Dysfunction in Sepsis. Journal of Interferon & Cytokine Research. https://doi.org/10.1089/jir.2025.0046
Vancouver
Li J, Apizi A, Song T, Kamilijiang P, Yu X, Chai R, et al. Inhibition of FKBP5 Alleviates Inflammation and Intestinal Barrier Dysfunction in Sepsis. Journal of Interferon & Cytokine Research. 2025. doi:10.1089/jir.2025.0046
BibTeX
@article{Li2025,
author = {Li, Jian and Apizi, Anwaier and Song, Tingting and Kamilijiang, Paiheriding and Yu, Xiangyou and Chai, Ruifeng and Yu, Zhaoxia},
title = {Inhibition of FKBP5 Alleviates Inflammation and Intestinal Barrier Dysfunction in Sepsis},
journal = {Journal of Interferon & Cytokine Research},
year = {2025},
doi = {10.1089/jir.2025.0046}
}
EUVIMED